Skip to main content

Advertisement

SpringerLink
Log in

Metabolomics as a tool for diagnosis and monitoring in coeliac disease

  • Review Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

Coeliac disease (CD) is a well defined condition contributed to by both genetic and environmental factors. The clinical management of CD is becoming increasingly complex as the disparity between symptoms, biological markers and mucosal pathology becomes more apparent. The only available treatment for CD is a life-long strict gluten-free diet (GFD), but up to 86 % of adult patients fail to achieve complete mucosal recovery even after 2 years of a GFD. The only accurate means of monitoring recovery on a GFD is via histology, which is cumbersome and resource intensive. Therefore, there is a need for novel non-invasive techniques for diagnosis and monitoring that are more accurate than serum antibodies in addition to an improved understanding of the disease mechanisms and obstacles to recovery. Metabolomics may address these needs. Metabolomics can be used to evaluate biomarkers associated with human disease from a variety of biological matrices including blood, urine and tissue samples. Through the comprehensive analysis of metabolites, metabolomics offers great promise for the early detection of CD and convenient monitoring of response to a GFD and perhaps an accurate means of assessing compliance to a GFD. As more evidence of the importance of gut microflora in human health accumulates, metabolomics may also be applied to investigate microbiome-metabolome interactions in CD for the most comprehensive understanding of this disease to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Anderson, R. P., Henry, M. J., Taylor, R., Duncan, E. L., Danoy, P., Costa, M. J., et al. (2013). A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Medicine, 11, 188–200. doi:10.1186/1741-7015-11-188.

    Article  PubMed Central  PubMed  Google Scholar 

  • Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schafer, H., Schutz, B., et al. (2008). Evidence of different metabolic phenotypes in humans. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1420–1424. doi:10.1073/pnas.0705685105.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Beckonert, O., Coen, M., Keun, H. C., Wang, Y. L., Ebbels, T. M. D., Holmes, E., et al. (2010). High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nature Protocols, 5(6), 1019–1032. doi:10.1038/nprot.2010.45.

    Article  CAS  PubMed  Google Scholar 

  • Bernini, P., Bertini, I., Calabro, A., la Marca, G., Lami, G., Luchinat, C., et al. (2011a). Are patients with potential celiac disease really potential? The answer of metabonomics. Journal of Proteome Research, 10(2), 714–721. doi:10.1021/pr100896s.

    Article  CAS  PubMed  Google Scholar 

  • Bernini, P., Bertini, I., Luchinat, C., Nepi, S., Saccenti, E., Schaefer, H., et al. (2009). Individual human phenotypes in metabolic space and time. Journal of Proteome Research, 8(9), 4264–4271. doi:10.1021/pr900344m.

    Article  CAS  PubMed  Google Scholar 

  • Bernini, P., Bertini, I., Luchinat, C., Nincheri, P., Staderini, S., & Turano, P. (2011b). Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. Journal of Biomolecular NMR, 49(3–4), 231–243. doi:10.1007/s10858-011-9489-1.

    Article  CAS  PubMed  Google Scholar 

  • Bertini, I., Cacciatore, S., Jensen, B. V., Schou, J. V., Johansen, J. S., Kruhøffer, M., et al. (2012). Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Research, 72(1), 356–364. doi:10.1158/0008-5472.CAN-11-1543.

  • Bertini, I., Calalbro, A., De Carli, V., Luchinat, C., Nepi, S., Porfirio, B., et al. (2009). The metabonomic signature of celiac disease. Journal of Proteome Research, 8(1), 170–177. doi:10.1021/pr800548z.

    Article  CAS  PubMed  Google Scholar 

  • Bjerrum, J. T., Nielsen, O. H., Hao, F., Tang, H., Nicholson, J. K., Wang, Y., et al. (2010). Metabonomics in ulcerative colitis: Diagnostics, biomarker identification, and insight into the pathophysiology. Journal of Proteomics, 9(2), 954–962. doi:10.1021/pr9008223.

  • Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., et al. (2013). The human urine metabolome. PLoS ONE, 8(9), e73076. doi:10.1371/journal.pone.0073076.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bustamante, S., Pickford, R., Shin, S., Luber, R., Campbell, B., Redmond, D., et al. (2010). Metabolomics in inflammatory bowel disease. Journal of Gastroenterology and Hepatology, 25(Suppl. 3), A83–A83.

  • Calavia, R., Annanouch, F. E., Correig, X., & Yanes, O. (2012). Nanostructure initiator mass spectrometry for tissue imaging in metabolomics: Future prospects and perspectives. Journal of Proteomics, 75(16), 5061–5068. doi:10.1016/j.jprot.2012.05.002.

    Article  CAS  PubMed  Google Scholar 

  • Catassi, C., Kryszak, D., Bhatti, B., Sturgeon, C., Helzlsouer, K., Clipp, S. L., et al. (2010). Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Annals of Medicine, 42(7), 530–538. doi:10.3109/07853890.2010.514285.

    Article  PubMed  Google Scholar 

  • Collino, S., Martin, F. P. J., & Rezzi, S. (2013). Clinical metabolomics paves the way towards future healthcare strategies. British Journal of Clinical Pharmacology, 75(3), 619–629. doi:10.1111/j.1365-2125.2012.04216.x.

    CAS  PubMed Central  PubMed  Google Scholar 

  • de Vos, W. M., & de Vos, E. A. J. (2012). Role of the intestinal microbiome in health and disease: From correlation to causation. Nutrition Reviews, 70, S45–S56. doi:10.1111/j.1753-4887.2012.00505.x.

    Article  PubMed  Google Scholar 

  • Denoroy, L., Zimmer, L., Renaud, B., & Parrot, S. (2013). Ultra high performance liquid chromatography as a tool for the discovery and the analysis of biomarkers of diseases: A review. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 927, 37–53. doi:10.1016/j.jchromb.2012.12.005.

    Article  CAS  Google Scholar 

  • Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., et al. (2011). Duodenal and faecal microbiota of celiac children: Molecular, phenotype and metabolome characterization. BMC Microbiology, 11(1), 219. doi:10.1186/1471-2180-11-219.

    Article  PubMed Central  PubMed  Google Scholar 

  • Di Cagno, R., Rizzello, C. G., Gagliardi, F., Ricciuti, P., Ndagijimana, M., Francavilla, R., et al. (2009). Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease. Applied and Environmental Microbiology, 75(12), 3963–3971. doi:10.1128/aem.02793-08.

    Article  PubMed Central  PubMed  Google Scholar 

  • Dube, C., Rostom, A., Sy, R., Cranney, A., Saloojee, N., Garritty, C., et al. (2005). The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology, 128(4), S57–S67. doi:10.1053/j.gastro.2005.02.014.

    Article  PubMed  Google Scholar 

  • Emwas, A. H. M., Salek, R. M., Griffin, J. L., & Merzaban, J. (2013). NMR-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations. Metabolomics, 9(5), 1048–1072. doi:10.1007/s11306-013-0524-y.

    Article  CAS  Google Scholar 

  • Gibney, M. J., Walsh, M., Brennan, L., Roche, H. M., German, B., & van Ommen, B. (2005). Metabolomics in human nutrition: Opportunities and challenges. American Journal of Clinical Nutrition, 82(3), 497–503.

    CAS  PubMed  Google Scholar 

  • Greving, M. P., Patti, G. J., & Siuzdak, G. (2011). Nanostructure-initiator mass spectrometry metabolite analysis and imaging. Analytical Chemistry, 83(1), 2–7. doi:10.1021/ac101565f.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hedrick, V. E., Dietrich, A. M., Estabrooks, P. A., Savla, J., Serrano, E., & Davy, B. M. (2012). Dietary biomarkers: Advances, limitations and future directions. Nutrition Journal, 11(1), 109. doi:10.1186/1475-2891-11-109.

    Article  PubMed Central  PubMed  Google Scholar 

  • Herman, M. L., Rubio-Tapia, A., Lahr, B. D., Larson, J. J., Van Dyke, C. T., & Murray, J. A. (2012). Patients with celiac disease are not followed up adequately. Clinical Gastroenterology and Hepatology, 10(8), 893. doi:10.1016/j.cgh.2012.05.007.

    Article  PubMed Central  PubMed  Google Scholar 

  • Hill, I. D. (2005). What are the sensitivity and specificity of serologic celiac disease? Do sensitivity and specificity vary in populations? Gastroenterology, 128(4), S25–S32. doi:10.1053/j.gastro.2005.02.012.

    Article  PubMed  Google Scholar 

  • Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011). Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends in Microbiology, 19(7), 349–359. doi:10.1016/j.tim.2011.05.006.

    Article  CAS  PubMed  Google Scholar 

  • Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008). Metabolic phenotyping in health and disease. Cell, 134(5), 714–717. doi:10.1016/j.cell.2008.08.026.

    Article  CAS  PubMed  Google Scholar 

  • Jiménez, B., Mirnezami, R., Kinross, J., Cloarec, O., Keun, H. C., Holmes, E., et al. (2013). 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. Journal of Proteome Research, 12(2), 959–968. doi:10.1021/pr3010106.

    Article  PubMed  Google Scholar 

  • Johnson, C. H., & Gonzalez, F. J. (2012). Challenges and opportunities of metabolomics. Journal of Cellular Physiology, 227(8), 2975–2981. doi:10.1002/jcp.24002.

    Article  CAS  PubMed  Google Scholar 

  • Koal, T., & Deigner, H. P. (2010). Challenges in mass spectrometry based targeted metabolomics. Current Molecular Medicine, 10(2), 216–226.

    Article  CAS  PubMed  Google Scholar 

  • König, S. (2011). Urine molecular profiling distinguishes health and disease: New methods in diagnostics? Focus on UPLC-MS. Expert Review of Molecular Diagnostics, 11(4), 383–391. doi:10.1586/erm.11.13.

    Article  PubMed  Google Scholar 

  • Koulman, A., Lane, G. A., Harrison, S. J., & Volmer, D. A. (2009). From differentiating metabolites to biomarkers. Analytical and Bioanalytical Chemistry, 394(3), 663–670. doi:10.1007/s00216-009-2690-3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Laurin, P., Falth-Magnusson, K., & Sundqvist, T. (2003). Increase in nitric oxide urinary products during gluten challenge in children with coeliac disease. Scandinavian Journal of Gastroenterology, 38(1), 55–60.

    Article  CAS  PubMed  Google Scholar 

  • Lindon, J. C., Beckonert, O. P., Holmes, E., & Nicholson, J. K. (2009). High-resolution magic angle spinning NMR spectroscopy: Application to biomedical studies. Progress in Nuclear Magnetic Resonance Spectroscopy, 55(2), 79–100. doi:10.1016/j.pnmrs.2008.11.004.

    Article  CAS  Google Scholar 

  • Losowsky, M. S. (2008). A history of coeliac disease. Digestive Diseases, 26(2), 112–120. doi:10.1159/000116768.

    Article  CAS  PubMed  Google Scholar 

  • Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., et al. (2013). The Oslo definitions for coeliac disease and related terms. Gut, 62(1), 43–52. doi:10.1136/gutjnl-2011-301346.

    Article  PubMed Central  PubMed  Google Scholar 

  • Martin, F.-P. J., Collino, S., & Rezzi, S. (2011). 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magnetic Resonance in Chemistry, 49, S47–S54. doi:10.1002/mrc.2810.

    Article  CAS  PubMed  Google Scholar 

  • Martin, F. P. J., Dumas, M. E., Wang, Y. L., Legido-Quigley, C., Yap, I. K. S., Tang, H. R., et al. (2007). A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Molecular Systems Biology, 3, 112. doi:10.1038/msb4100153.

    Article  PubMed Central  PubMed  Google Scholar 

  • Martin, F. P. J., Montoliu, I., Kochhar, S., & Rezzi, S. (2010). Chemometric strategy for modeling metabolic biological space along the gastrointestinal tract and assessing microbial influences. Analytical Chemistry, 82(23), 9803–9811. doi:10.1021/ac102015n.

    Article  CAS  PubMed  Google Scholar 

  • Mooney, P. D., Hadjivassiliou, M., & Sanders, D. S. (2014). Coeliac disease. BMJ, 348, 1–8. doi:10.1136/bmj.g1561.

    Google Scholar 

  • Nicholson, J. K., Holmes, E., Kinross, J. M., Darzi, A. W., Takats, Z., & Lindon, J. C. (2012). Metabolic phenotyping in clinical and surgical environments. Nature, 491(7424), 384–392. doi:10.1038/nature11708.

    Article  CAS  PubMed  Google Scholar 

  • Primrose, S., Draper, J., Elsom, R., Kirkpatrick, V., Mathers, J. C., Seal, C., et al. (2011). Metabolomics and human nutrition. The British Journal of Nutrition, 105(8), 1277–1283. doi:10.1017/s0007114510004812.

    Article  PubMed  Google Scholar 

  • Reimund, J. M., Duclos, B., Koehl, C., Lehr, L., Ezenfis, J., & Baumann, R. (1999). Nitric oxide end products in patients hospitalized for diarrhoea. European Journal of Gastroenterology and Hepatology, 11(9), 1013–1018. doi:10.1097/00042737-199909000-00011.

    Article  CAS  PubMed  Google Scholar 

  • Ryan, D., & Robards, K. (2006). Metabolomics: The greatest omics of them all? Analytical Chemistry, 78(23), 7954–7958. doi:10.1021/ac0614341.

    Article  CAS  PubMed  Google Scholar 

  • Ryan, D., Robards, K., Prenzler, P. D., & Kendall, M. (2011). Recent and potential developments in the analysis of urine: A review. Analytica Chimica Acta, 684(1–2), 17–29. doi:10.1016/j.aca.2010.10.035.

    Article  CAS  Google Scholar 

  • Sanchez, E., De Palma, G., Capilla, A., Nova, E., Pozo, T., Castillejo, G., et al. (2011). Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by bacteroides species. Applied and Environmental Microbiology, 77(15), 5316–5323. doi:10.1128/aem.00365-11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Scalbert, A., Brennan, L., Fiehn, O., Hankemeier, T., Kristal, B. S., van Ommen, B., et al. (2009). Mass-spectrometry-based metabolomics: Limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics, 5(4), 435–458. doi:10.1007/s11306-009-0168-0.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Scalbert, A., Brennan, L., Manach, C., Andres-Lacueva, C., Dragsted, L. O., Draper, J., et al. (2014). The food metabolome: A window over dietary exposure. American Journal of Clinical Nutrition, 99(6), 1286–1308. doi:10.3945/ajcn.113.076133.

    Article  CAS  PubMed  Google Scholar 

  • Schippa, S., Iebba, V., Barbato, M., Di Nardo, G., Totino, V., Checchi, M. P., et al. (2010). A distinctive ‘microbial signature’ in celiac pediatric patients. BMC Microbiology, 10, 175. doi:10.1186/1471-2180-10-175.

    Article  PubMed Central  PubMed  Google Scholar 

  • Sellitto, M., Bai, G. Y., Serena, G., Fricke, W. F., Sturgeon, C., Gajer, P., et al. (2012). Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One, 7(3), e33387. doi:10.1371/journal.pone.0033387.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sharkey, L. M., Corbett, G., Currie, E., Lee, J., Sweeney, N., & Woodward, J. M. (2013). Optimising delivery of care in coeliac disease—comparison of the benefits of repeat biopsy and serological follow-up. Alimentary Pharmacology & Therapeutics, 38(10), 1278–1291. doi:10.1111/apt.12510.

    Article  CAS  Google Scholar 

  • van Ommen, B., Bouwman, J., Dragsted, L. O., Drevon, C. A., Elliott, R., de Groot, P., et al. (2010). Challenges of molecular nutrition research 6: The nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes and Nutrition, 5(3), 189–203. doi:10.1007/s12263-010-0167-9.

    Article  PubMed Central  PubMed  Google Scholar 

  • Wang, Y., Holmes, E., Comelli, E. M., Fotopoulos, G., Dorta, G., Tang, H., et al. (2007). Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning H-1 NMR spectroscopy. Journal of Proteome Research, 6(10), 3944–3951. doi:10.1021/pr0702565.

    Article  CAS  PubMed  Google Scholar 

  • Wang, H. L., Tso, V. K., Slupsky, C. M., & Fedorak, R. N. (2010). Metabolomics and detection of colorectal cancer in humans: A systematic review. Future Oncology, 6(9), 1395–1406. doi:10.2217/fon.10.107.

    Article  CAS  PubMed  Google Scholar 

  • Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., et al. (2013). HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Research, 41(D1), D801–D807. doi:10.1093/nar/gks1065.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wishart, D. S., Querengesser, L. M. M., Lefebvre, B. A., Epstein, N. A., Greiner, R., & Newton, J. B. (2001). Magnetic resonance diagnostics: A new technology for high-throughput clinical diagnostics. Clinical Chemistry, 47(10), 1918–1921.

    Google Scholar 

  • Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., et al. (2007). HMDB: The human metabolome database. Nucleic Acids Research, 35, D521–D526. doi:10.1093/nar/gkl923.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang, A. H., Sun, H., Wang, P., Han, Y., & Wang, X. J. (2012). Recent and potential developments of biofluid analyses in metabolomics. Journal of Proteomics, 75(4), 1079–1088. doi:10.1016/j.jprot.2011.10.027.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Compliance with Ethical Requirements

This article does not contain any studies with human or animal subjects.

Author information

Authors and Affiliations

  1. Graham Centre for Agricultural Innovation, School of Agricultural and Wine Sciences, Charles Sturt University, Locked Bag 588, Wagga Wagga, NSW, 2678, Australia

    Danielle Ryan & Paul D. Prenzler

  2. Department of Gastroenterology, Eastern Health Clinical School, Monash University, Box Hill, VIC, 3128, Australia

    Evan D. Newnham

  3. Department of Gastroenterology, Alfred Hospital, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia

    Peter R. Gibson

Authors
  1. Danielle Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evan D. Newnham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul D. Prenzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter R. Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danielle Ryan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ryan, D., Newnham, E.D., Prenzler, P.D. et al. Metabolomics as a tool for diagnosis and monitoring in coeliac disease. Metabolomics 11, 980–990 (2015). https://doi.org/10.1007/s11306-014-0752-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11306-014-0752-9

Keywords

Search

Navigation